Four British climbers became the first to scale Mount Everest on Wednesday using Xenon gas, which helped them save several ...

A live audio webcast of the company presentation will be available on the “Investors” section of Xenon's website and posted for replay following the event. The above listed dates and times are ...

The itinerary is simple. Four British men hopped on a plane Friday in London, flew roughly 4,600 miles to Kathmandu in Nepal and then boarded a helicopter to Mount Everest’s base camp.

Xenon Pharmaceuticals XENE reported a loss of 83 cents per share for the first quarter of 2025, narrower than the Zacks Consensus Estimate of a loss of 94 cents. The company had incurred a loss of ...

Fintel reports that on May 14, 2025, Evercore ISI Group initiated coverage of Xenon Pharmaceuticals (NasdaqGM:XENE) with a Outperform recommendation. As of May 7, 2025, the average one-year price ...

Analyst Price Forecast Suggests 64.06% Upside As of April 24, 2025, the average one-year price target for Xenon Pharmaceuticals is $57.71/share. The forecasts range from a low of $42.42 to a high ...

Fintel reports that on May 7, 2025, Chardan Capital initiated coverage of Xenon Pharmaceuticals (NasdaqGM:XENE) with a Buy recommendation. As of April 24, 2025, the average one-year price target ...

Investing.com -- Xenon Pharmaceuticals Inc. (NASDAQ:XENE) shares tumbled 10.7% after the neuroscience-focused biopharmaceutical company reported first quarter earnings and announced a delay in ...

While this timing represents a modest shift from our prior guidance, we are encouraged that we are nearing the end of this important study which represents a significant milestone for Xenon ...

BURNABY, British Columbia (AP) — BURNABY, British Columbia (AP) — Xenon Pharmaceuticals Inc. (XENE) on Monday reported a loss of $65 million in its first quarter. On a per-share basis ...